TERC and cancer: A report utilizing an antisense oligonucleotide targeting TERC showed that the antisense oligonucleotide effectively attenuated TERC expression and inhibited TERT activity in TERT-positive cancer cells, leading to cell death through a more robust induction of apoptosis specifically in TERT-positive cancer cells [91].